This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Gemvax as. Active years: 2006-2012.
Company Filing History:
Years Active: 2006-2012
Title: Stein Sæbøe-Larssen: Innovator in Cancer Immunotherapy
Introduction
Stein Sæbøe-Larssen is a prominent inventor based in Oslo, Norway. He has made significant contributions to the field of cancer immunotherapy, holding 2 patents that focus on innovative approaches to combat cancer through immune response.
Latest Patents
His latest patents include groundbreaking work on nucleic acids encoding novel TERT polypeptides. These inventions relate to polypeptides and nucleic acids capable of eliciting an immune reaction against cancer. They also encompass methods for generating T lymphocytes that can recognize and destroy tumor cells, along with pharmaceutical compositions for the treatment, prophylaxis, or diagnosis of cancer.
Career Highlights
Stein Sæbøe-Larssen is currently associated with Gemvax AS, where he continues to advance his research and development efforts in cancer treatment. His work is pivotal in the ongoing fight against cancer, aiming to improve patient outcomes through innovative therapies.
Collaborations
He collaborates with notable colleagues such as Gustav Gaudernack and Mona Møller, contributing to a dynamic research environment focused on cancer immunotherapy.
Conclusion
Stein Sæbøe-Larssen's contributions to cancer research through his patents and collaborations highlight his commitment to advancing medical science. His work is essential in the quest for effective cancer treatments.